Letter to the Editor
Blood safety and the choice of anti-hemophilic factor concentrate
First published: 24 October 2006
No abstract is available for this article.
REFERENCES
- 1
Eriksson RK,
Fenge C,
Lindner-Olsson E, et al.
The manufacturing process for B-domain deleted recombinant factor VIII.
Semin Hematol
2001;
38:
24–31.
- 2
Harrison S,
Adamson S,
Bonam D, et al.
The manufacturing process for recombinant factor IX.
Semin Hematol
1988;
35:
4–10.
